期刊
INTERNATIONAL JOURNAL OF STD & AIDS
卷 24, 期 2, 页码 85-92出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0956462412472837
关键词
gonorrhoea; European clinical guideline; management; Neisseria gonorrhoeae; diagnosis; antimicrobial resistance; antimicrobial treatment; antibiotic
资金
- Department of Health [DRF-2011-04-116] Funding Source: Medline
- National Institutes of Health Research (NIHR) [DRF-2011-04-116] Funding Source: National Institutes of Health Research (NIHR)
Gonorrhoea is a major public health concern globally. Of particularly grave concern is that resistance to the extended-spectrum cephalosporins has emerged during the most recent years. This guideline provides recommendations regarding the diagnosis and treatment of gonorrhoea in Europe. Compared to the outdated 2009 European gonorrhoea guideline, this 2012 European gonorrhoea guideline provides up-to-date guidance on, broader indications for testing and treatment of gonorrhoea; the introduction of dual antimicrobial therapy (ceftriaxone 500 mg and azithromycin 2 g) for uncomplicated gonorrhoea when the antimicrobial sensitivity is unknown; recommendation of test of cure in all gonorrhoea cases to ensure eradication of infection and identify emerging resistance; and recommendations to identify, verify and report failures with recommended treatment regimens. Optimisations of the testing, diagnostics, antimicrobial treatment and follow-up of gonorrhoea patients are crucial in controlling the emergent spread of cephalosporin-resistant and multidrug-resistant gonorrhoea.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据